org 31710 has been researched along with telapristone acetate in 1 studies
| Studies (org 31710) | Trials (org 31710) | Recent Studies (post-2010) (org 31710) | Studies (telapristone acetate) | Trials (telapristone acetate) | Recent Studies (post-2010) (telapristone acetate) |
|---|---|---|---|---|---|
| 38 | 3 | 6 | 26 | 5 | 19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gamarra-Luques, CD; Goyeneche, AA; Hapon, MB; Telleria, CM | 1 |
1 other study(ies) available for org 31710 and telapristone acetate
| Article | Year |
|---|---|
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity.
Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estrenes; Female; Furans; Hormone Antagonists; Humans; Inhibitory Concentration 50; Mifepristone; Norpregnadienes; Paclitaxel | 2014 |